Your browser doesn't support javascript.
loading
BRAF Immunoexpression Can Be Intralesionally Heterogeneous but BRAF V600E Mutation Status Is Intralesionally Homogeneous and Interlesionally Concordant in Melanoma: A Study of 140 Lesions From 98 Patients.
Tachibana, Kota; Goto, Keisuke; Kukita, Yoji; Honma, Keiichiro; Isei, Taiki; Sugihara, Satoru; Taniguchi, Kohei; Yamasaki, Osamu.
Affiliation
  • Tachibana K; Department of Dermatologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Goto K; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Kukita Y; Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Honma K; Melanoma Center, Okayama University Hospital, Okayama, Japan.
  • Isei T; Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan.
  • Sugihara S; Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
  • Taniguchi K; Department of Pathology, Itabashi Central Clinical Laboratory, Tokyo, Japan.
  • Yamasaki O; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
Am J Dermatopathol ; 44(7): 478-487, 2022 Jul 01.
Article in En | MEDLINE | ID: mdl-35120030

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Melanoma Limits: Humans Language: En Journal: Am J Dermatopathol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins B-raf / Melanoma Limits: Humans Language: En Journal: Am J Dermatopathol Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United States